Prenatal Administration of Heparin-Binding EGF-Like Growth Factor (HB-EGF) In An Experimental Model Of Necrotizing Enterocolitis Decreased Neuroinflammation In The Neonatal Brain by Mendez, Yomara
Loma Linda Student Journal 
© Loma Linda University   
LLUSJ 4(1);Jul:2020  Mendez et al. 
13 
Prenatal Administration of Heparin-Binding EGF-Like 
Growth Factor (HB-EGF) In An Experimental Model Of 
Necrotizing Enterocolitis Decreased Neuroinflammation 
In The Neonatal Brain 
 
Yomara S. Mendez1, Jonathan Abdala2, Amanda Munoz1, Robert Propst3, Craig W. Zuppan3, 
Christopher G. Wilson2, Andrei Radulescu1 
1 Department of Pediatric Surgery, Loma Linda University Children's Hospital, Loma Linda, CA, United States 
2 Department of Neonatology, Loma Linda University Children's Hospital, Loma Linda, CA, United States 
3 Department of Pathology, Loma Linda University Children's Hospital, Loma Linda, CA, United States 
 
INTRODUCTION AND OBJECTIVES: 
Necrotizing enterocolitis (NEC) is the 
leading gastrointestinal cause of death in 
premature infants. Postnatal enterally 
administered Heparin-Binding EGF-like 
Growth Factor (HB-EGF) decreases the 
incidence and severity of intestinal injury in 
a neonatal rat model of NEC. In this study, 
we hypothesized that NEC-induced 
inflammation would increase the expression 
of cytokines in the autonomic control regions 
of the nucleus tractus solitarii (NTS) and that 
prenatal administration of HB-EGF would 
decreased the incidence of NEC and 
associated neuroinflammation. 
 
METHODS: HB-EGF 800 µg/kg/dose, was 
delivered by means of tail vein injection or 
intraperitoneally 2 hours prior to delivery of 
the rat pups. Rat pups were delivered 
prematurely by C-section and subjected to 
NEC protocol. Pups were sacrificed upon 
signs of NEC and intestines were harvested 
and graded. Cytokine expression in the pup 
brain (IL-1β, IL-6, TNFα) was assessed. 
 
RESULTS: Compared to untreated pups, the 
prenatal administration of HB-EGF to 
pregnant female rats significantly decreases 
the incidence and severity of NEC in rat pups 
with best results seen when HB-EGF is 
administered in an intraperitoneal fashion 2 
hours before C-section. (62.9% vs 30%*, p 
=0.02) IL-6 was not significantly different in 
the untreated pups versus pups that received 
HB-EGF prenatally (p= 0.75) but IL-1β and 
TNFα were significantly reduced by tail 
injections at 2 hours prior to birth (p =0.0018 
IL-1β and p=0.00005 TNFα). 
 
CONCLUSIONS: Prenatal HB-EGF 
administration decreases the incidence and 
severity of experimental NEC and reduces 
the inflammatory markers. This suggests a 
novel prophylactic strategy that could have 
beneficial neurodevelopmental effects in 
NEC patients. 
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